Early Warning and Behavioural Intervention on the Cardiovascular Disease Risk in People Living with HIV: A Multicentre Non-Randomized Controlled Trial.
Proactive cardiovascular screening plus behavior change counseling in people with HIV addresses their elevated heart disease risk from dual factors.
This multicentre non-randomized trial evaluated early CVD risk warning plus behavioural intervention in people living with HIV, a population with elevated cardiometabolic risk from both HIV-related inflammation and antiretroviral therapy effects. The study provides evidence for a structured prevention approach in this high-risk intersection population, relevant to both cardiovascular-metabolic surveillance and infectious disease care.
What the study was
- Study design
- Non-randomized controlled trial (multicenter)
- Population
- People living with HIV (PLHIV) at elevated CVD risk across multiple centers in China
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- Infectious Diseases and Therapy
Why it surfaced
Multicentre controlled trial addressing CVD risk prevention in HIV-positive patients; T7-adjacent; identified via sentinel scan as unsolicited find.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.